[spacer image]
BD
BD - Worldwide
Select Another Location
[spacer image] [spacer image] Physicians [spacer image] Labs [spacer image]
[spacer image] [spacer image]
TriPath
[spacer image]
Cervical Cytology BD SurePath™
Pap Test BD Cell Enrichment
Process BD PrepStain™
Slide Processor BD FocalPoint™
Slide Profiler BD FocalPoint™
GS Imaging System Detection
[spacer image]
Molecular Oncology
[spacer image]
Non-Gyn
[spacer image]
Product Inserts
[spacer image]
MSDS Documents
[spacer image]
Resources
[spacer image]
Contact Us
[spacer image]
Labs Main Page
[spacer image]
TriPath Home
[spacer image]
[spacer image]

Did you know?
[spacer image] BD manufactured the first syringe made specifically for insulin injection. Learn more about BD's history » [spacer image]
[spacer image]


Cervical Cytology
Email Page Print
[spacer image]
BD FocalPoint™ GS Imaging System

 
 

Features

Features of the BD FocalPoint™ GS Imaging System are, but are not limited to:
 
  •  
    		• Intelligent Pap Imaging™
  •  
    		• Specific Endo-cervical cell detection algorithms
  •  
    		• No restriction of high risk patient samples
  •  
    		•  Scalable to fit your lab’s volume
  •  
    		•  Ethernet networking capability
  •  
    		•  Interface capabilities – LIS
  •  
    		• Reporting capabilities
  •  
    		•  No specific stain required
  •  
    		• Directed QC Technology™
  •  
    		•  Slide and Field of View (FOV) ranking
  •  
    		•  Ranking, adequacy, and slide status
  •  
    		•  Supports most commonly used laboratory microscopes
  •  
    		• 170 slides processed/8hr workday
     

    Benefits

    The BD FocalPoint™ GS Imaging System received FDA approval on December 3rd of 2008 with a clinical claim of increased disease detection & productivity. Click here to view press release
     
    The BD FocalPoint™ GS Imaging System provides for a statistically higher increase in disease detection in the following categories:
     
  •  
    		•  24.5% increase in Cancer sensitivity
  •  
    		• 9.8% increase in LSIL+ sensitivity
  •  
    		• 19.6% increase in HSIL+ sensitivity
  •  
    		•  9.2% increase in ASC-H+ sensitivity
     
    Finally, the overall ASC/SIL ratio decreased 42% in the BD FocalPoint™ GS arm which means more definitive answers with “fewer maybes for your customers”.
     
    For product related inquiries, please contact BDFocalPointGS@bd.com or dial 1-866-TriPath.
     
    		[spacer image]
    [spacer image] [spacer image] [spacer image]
    [spacer image] [spacer image] [spacer image]
    [spacer image]
    Site Map
    Terms & Conditions | Permission Request | Trademarks
    BD Worldwide
    BD
    1 Becton Drive
    Franklin Lakes, NJ USA 07417
    201.847.6800
    Unless otherwise noted, BD, BD Logo and all other trademarks are property of Becton, Dickinson and Company. © 2010 BD